The first baby monitor that analyses the baby’s crying and helps parents understand the need of their newborn enters the market.
How many parents have felt powerless when hearing their newborn cry? Drawing upon his own experience as a parent, Roberto Iannone, Zoundream CEO, and his team have developed a solution using AI to help parents understand why babies are crying.
Dorel Juvenile has partnered with health-tech startup Zoundream to embed their Cry Analysis AI technology in the new Maxi Cosi See Pro baby monitor. This advanced feature will help parents recognize and respond to their babies’ needs more quickly and more accurately.
A big brand for baby products
We are thrilled to see our DayOne alumnus Zoundream collaborating with Dorel Juvenile, a market leading expert in baby products, well-known for its global brands Maxi-Cosi, Safety 1st and Tiny Love, complemented by regional brands such as BebeConfort, Cosco, Mother’s Choice and Infanti.
The fruit of their collaboration was launched on 7 September 2023 at the “Kind + Jugend” fair in Cologne, the biggest fair worldwide for baby and children’s equipment.
Helping parents understand their babies’ needs
Zoundream is a health-tech startup based at the Switzerland Innovation Park Basel Area – site Novartis Campus in Basel, Switzerland, with its engineering center in Barcelona, Spain. The company was founded in 2019 to help parents better understand and address their babies’ needs. Zoundream was then selected for the DayOne accelerator and joined the 2019/2020 cohort.
The company develops solutions to provide continuous non-invasive monitoring of infants’ health, while at their homes – from translating the meaning of baby cries to early detection of potential neurodevelopmental disorders and pathologies.
DayOne Health 4.0 accelerator for you?
If you want to bring your healthtech idea to success, the six-month hybrid DayOne Health 4.0 in the Basel Area might be the right accelerator for you. Get support for innovating across the healthcare spectrum, from diagnosis to prevention, patient and caregiver communication, and solutions for healthcare professionals.
The 2023 edition, running from September 2023 to March 2024, focuses on artificial intelligence, data and digitally enhanced clinical development.
